Quantitative Whole Genome Analysis of Sequential Samples From Patients with B CLL Identifies Novel Recurrent Copy Number Alterations Involving Critical B Cell Transcription Factors

Quantitative Whole Genome Analysis of Sequential Samples From Patients with B CLL Identifies Novel Recurrent Copy Number Alterations Involving Critical B Cell Transcription Factors

Show other versions (1)

Bibliographic Details
Main Authors:	Timbs, A, Knight, S, SadighiAkha, E, Burns, A, Dreau, H, Hewitt, A, Hatton, C, Yau, C, Holmes, C, Taylor, J, Schuh, A
Format:	Conference item
Published:	2010

Similar Items

Quantitative Whole Genome Analysis of Sequential Samples From Patients with B-CLL Identifies Novel Recurrent Copy Number Alterations Involving Critical B-Cell Transcription Factors
by: Timbs, A, et al.
Published: (2010)

Identification of Novel Recurrent Copy Number Variations and Regions of Copy-Neutral Loss of Heterozygosity by High Resolution Genomic Array in Pre-Treatment and Relapsed B-CLL.
by: Knight, S, et al.
Published: (2009)

IDENTIFICATION OF NOVEL RECURRENT COPY NUMBER VARIATIONS BY HIGH RESOLUTION COMPARATIVE GENOME HYBRIDISATION
by: Schuh, A, et al.
Published: (2009)

Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.
by: Knight, S, et al.
Published: (2012)

Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.
by: Knight, S, et al.
Published: (2012)

Clinical‐grade validation of whole genome sequencing reveals robust detection of low‐frequency variants and copy number alterations in CLL
by: Klintman, J, et al.
Published: (2018)

UK experience of Ofatumumab in refractory B-CLL
by: Varghese, A, et al.
Published: (2011)

NF-kB and the CLL microenvironment
by: Alice O’Donnell, et al.
Published: (2023-03-01)

SAMHD1, A Putative Tumour Suppressor, Is Recurrently Mutated in Chronic Lymphocytic Leukaemia, and Is Associated with Poor Risk Features
by: Clifford, R, et al.
Published: (2012)

Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL.
by: Guièze, R, et al.
Published: (2015)

Targeted Gene Profiling Identifies Differential Genetic Make-up Depending On Chronic Lymphocytic Leukaemia Subtype
by: Burns, A, et al.
Published: (2012)

Targeted Gene Profiling Identifies Differential Genetic Make-up Depending On Chronic Lymphocytic Leukaemia Subtype
by: Burns, A, et al.
Published: (2012)

Screening for clinically significant non-deletional alpha thalassaemia mutations by pyrosequencing.
by: Haywood, A, et al.
Published: (2010)

Diagnosis of B-CLL Leukemia Using Fractal Dimension
by: Tohid Yousefzadeh Hassanluie, et al.
Published: (2017-07-01)

BTLA Expression in CLL: Epigenetic Regulation and Impact on CLL B Cell Proliferation and Ability to IL-4 Production
by: Lidia Karabon, et al.
Published: (2021-11-01)

Spatial organization and early signaling of the B-cell receptor in CLL
by: Yamit Shorer Arbel, et al.
Published: (2022-08-01)

Dual copy number variants involving 16p11 and 6q22 in a case of childhood apraxia of speech and pervasive developmental disorder.
by: Newbury, D, et al.
Published: (2013)

Nine Novel Mutations in the Erythroid Transcription Factor KLF1 Gene Associated with Increased Fetal Hemoglobin Levels in Adults
by: Gallienne, A, et al.
Published: (2011)

Dual copy number variants involving 16p11 and 6q22 in a case of childhood apraxia of speech and pervasive developmental disorder
by: Newbury, D, et al.
Published: (2013)

Results of the randomised phase II NCRI arctic (attenuated dose rituximab with chemotherapy in CLL) trial of low dose rituximab in previously untreated CLL
by: Munir, T, et al.
Published: (2014)

Utility of whole-genome sequencing in the clinical diagnostic of rare inherited anaemias
by: C Camps, et al.
Published: (2018)

Progressive Multifocal Leukoencephalopathy in B-CLL Successfully Treated With Venetoclax and Pembrolizumab
by: Jacopo Olivieri, et al.
Published: (2022-06-01)

Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia. Krohem B-Cll 2017
by: Branimir Jakšić, et al.
Published: (2018-01-01)

Bayesian Nonparametric Hidden Markov Models with application to the analysis of copy-number-variation in mammalian genomes.
by: Yau, C, et al.
Published: (2008)

Bayesian Nonparametric Hidden Markov Models with application to the analysis of copy-number-variation in mammalian genomes.
by: Yau, C, et al.
Published: (2011)

Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV(mut) and IgHV(unmut) subgroups
by: Burns, A, et al.
Published: (2017)

CLL stereotyped B-cell receptor immunoglobulin sequences are recurrent in the B-cell repertoire of healthy individuals: Apparent lack of central and early peripheral tolerance censoring
by: Stefano Vergani, et al.
Published: (2023-03-01)

Response to therapy and survival in CLL is influenced by genetic markers. preliminary analysis from the LRF CLL4 trial.
by: Catovsky, D, et al.
Published: (2004)

Ofatumumab retreatment and maintenance in patients with fludarabine-refractory CLL.
by: Osterborg, A, et al.
Published: (2012)

Multiplex ligation-dependent probe amplification identification of 17 different beta-globin gene deletions (including four novel mutations) in the UK population.
by: Gallienne, A, et al.
Published: (2009)

Challenges in Diagnosis and Clinical Management of COVID-19 in Patient with B-Cell Chronic Lymphocytic Leukemia (CLL): Report of One Case
by: Vincenzo Visco, et al.
Published: (2022-03-01)

Quality of life in the UK LRF CLL4 trial (on behalf of the UKNCRI CLL Trials Group)
by: Else, M, et al.
Published: (2006)

Enhanced Expression of <i>miR-181b</i> in B Cells of CLL Improves the Anti-Tumor Cytotoxic T Cell Response
by: Mirco Di Marco, et al.
Published: (2021-01-01)

Concomitant Presence of CD5-Positive Diffuse Large B-Cell Lymphoma and Monoclonal B Cells with the 'CLL Immunophenotype' - Is It Richter's Transformation?
by: Sabina Langer, et al.
Published: (2017-05-01)

Glucosylceramide synthetase inhibitors sensitise B-CLL cells to cytotoxic agents without reversing P-gp functional activity.
by: Gerrard, G, et al.
Published: (2004)

Elusive copy number variation in the mouse genome.
by: Agam, A, et al.
Published: (2010)

Editorial: Biology and treatment of high-risk CLL
by: Eugen Tausch, et al.
Published: (2023-02-01)

Glabellar and auricular leukemia cutis in CLL
by: Bradley Steinman, et al.
Published: (2022-11-01)

P1277: MUTATIONAL LANDSCAPE AND COPY NUMBER ALTERATIONS IN TESTICULAR LARGE B-CELL LYMPHOMA
by: C. López, et al.
Published: (2022-06-01)

Altered DNA Methylation Profiles in <i>SF3B1</i> Mutated CLL Patients
by: Alicja Pacholewska, et al.
Published: (2021-08-01)